Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
Article
Statins and Insulin Resistance
Read time: 1h 1m 1s
About
Media
Watch time: 4m 53s
Watch time: 4m 57s
Watch time: 8m 2s
Watch time: 3m 25s
Watch time: 4m 43s
Watch time: 4m 14s
Watch time: 7m 48s
Watch time: 7m 44s
Watch time: 10m 34s
Watch time: 9m 40s
Articles
How Do We Approach Low High-density Lipoprotein Cholesterol in 2011?
Citation:
European Cardiology 2011;7(4):257–63
- Views:
194
- Downloads:
0
Managing Dyslipidaemic Patients - Improving Adherence with Lifestyle Intervention
Citation:
European Cardiology 2011;7(4):246–50
- Views:
207
- Downloads:
0
Urine Albumin to Creatinine Ratio and Echocardiographic Left Ventricular Structure and Function in Patients with Essential Hypertension
Citation:
American Heart Hospital Journal 2011;9(2):90-4
- Views:
253
- Downloads:
0
Atherosclerosis Plaque Imaging and Characterization Using Magnetic Resonance Imaging
Citation:
US Cardiology 2005;2(1):129-32
- Views:
75
- Downloads:
0